DETERMINING NORMAL PRION PROTEIN FUNCTION, EMPHASISING THE ROLE PLAYED BY PROTEIN CLEAVAGE, AND ALSO DEFINING THE RELATIONSHIP BETWEEN SURVEILLANCE INTENSITY AND ANNUAL SPORADIC CJD INCIDENCE
Grant number: 1005816 | Funding period: 2011 - 2015
As a neurologist undertaking research into prion diseases over an extended period, I have been able to lead and participate in many projects that have made significant contributions, such as validation of new diagnostic tests for Creutzfeldt-Jakob disease (CJD), assessment of potential therapeutics, provide insights into the normal function of the prion protein and the underlying pathways causing cellular damage and determine the real significance of apparent clusters of sporadic CJD.
Related publications (8)
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology
Alan Rembach, Lisbeth A Evered, Qiao-Xin Lii, Tabitha Nash, Lesley Vidaurre, Christopher J Fowler, Kelly K Pertile, Rebecca L Rumble, Brett O Trounson, Sarah Maher, Francis Mooney, Maree Farrow, Kevin Taddei, Stephanie Rainey-Smith, Simon M Laws, S Lance Macaulay, William Wilson, David G Darby, Ralph N Martins, David Ames
Unusual Clinical and Molecular-Pathological Profile of Gerstmann-Straussler-Scheinker Disease Associated With a Novel PRNP Mutation (V176G)
Marion Simpson, Vanessa Johanssen, Alison Boyd, Genevieve Klug, Colin L Masters, Qiao-Xin Li, Roger Pamphlett, Catriona McLean, Victoria Lewis, Steven J Collins
Immunotherapeutic approaches in prion disease: progress, challenges and potential directions.
Marcus W Brazier, Alexandra I Mot, Anthony R White, Steven J Collins
Therapeutic trials utilizing animal models of prion disease have explored a variety of compounds and a number of approaches with v..